Goldman Sachs Initiates Pharmerica With Neutral
September 11, 2014 at 08:03 AM EDT
Analysts at Goldman Sachs initiated coverage on shares of Pharmerica (NYSE: PMC) with a Neutral rating. The target price for ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.